Paul Loubet

Dr. Paul Loubet

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2021 in Toxins
Verified
Journal Article
Open access
PDF file
NMNour Mansour
Nour Mansour
PLPaul Loubet
Paul Loubet
CPCassandra POUGET
Cassandra POUGET
CDCatherine Dunyach-Remy
Catherine Dunyach-Remy
ASAlbert Sotto
Albert Sotto
VMVirginie MOLLE
Virginie MOLLE
Staphylococcus aureus is a clinically important pathogen that causes a wide range of human infections, from minor skin infections to severe tissue infection and sepsis. S. aureus has a high level of antibiotic resistance and is a common cause of infections in hospitals and the community. The rising prevalence of community-acquired methicillin-resistant S. aureus (CA-MRSA), combined with the important severity of S. aureus infections in general, has resulted in the frequent use of anti-staphylococcal antibiotics, leading to increasing resistance rates. Antibiotic-resistant S. aureus continues to be a major health concern, necessitating the development of novel therapeutic strategies. S. aureus uses a wide range of virulence factors, such as toxins, to develop an infection in the host. Recently, anti-virulence treatments that directly or indirectly neutralize S. aureus toxins have showed promise. In this review, we provide an update on toxin pathogenic characteristics, as well as anti-toxin therapeutical strategies.

1 July 2015 in Vaccine
Verified
Journal Article
Closed access
PLPaul Loubet
Paul Loubet
SKSolen Kernéis
Solen Kernéis
MGMatthieu Groh
Matthieu Groh
PLPierre Loulergue
Pierre Loulergue
PBPhilippe Blanche
Philippe Blanche
OLOdile Launay
Odile Launay

1 April 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PLPaul Loubet
Paul Loubet
NLN. Lenzi
N. Lenzi
MVM. Valette
M. Valette
VFV. Foulongne
V. Foulongne
AKA. Krivine
A. Krivine
IGI. Goderel
I. Goderel

1 June 2017 in Journal of Clinical Virology
Verified
Journal Article
Closed access
PLPaul Loubet
Paul Loubet
GVGuillaume Voiriot
Guillaume Voiriot
NHNadhira Houhou-Fidouh
Nadhira Houhou-Fidouh
MNMathilde Neuville
Mathilde Neuville
LBLila Bouadma
Lila Bouadma
BVBenoit Visseaux
Benoit Visseaux

1 June 2016 in Journal of Clinical Virology
Verified
Journal Article
Closed access
PLPaul Loubet
Paul Loubet
NSNezha Samih-Lenzi
Nezha Samih-Lenzi
FGFlorence Galtier
Florence Galtier
PVPhilippe Vanhems
Philippe Vanhems
PLPierre Loulergue
Pierre Loulergue
OLOdile Launay
Odile Launay

12 September 2024 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
FVFanny Villa
Fanny Villa
HMHélène Marchandin
Hélène Marchandin
Jean-Philippe LavigneJean-Philippe Lavigne
Jean-Philippe Lavigne
SSSophie Schuldiner
Sophie Schuldiner
NCNicolas Cellier
Nicolas Cellier
PLPaul Loubet
Paul Loubet
SUMMARY: Diabetic foot infections (DFI) are a public health problem worldwide. DFI are polymicrobial, biofilm-associated infections involving complex bacterial communities organized in functional equivalent pathogroups, all including anaerobes. Indeed, multiple pathophysiological factors favor the growth of anaerobes in this context. However, the prevalence, role, and contribution of anaerobes in wound evolution remain poorly characterized due to their challenging detection. Studies based on culture reviewed herein showed a weighted average of 17% of patients with anaerobes. Comparatively, the weighted average of patients with anaerobes identified by 16S rRNA gene sequencing was 83.8%. Culture largely underestimated not only the presence but also the diversity of anaerobes compared with cultivation-independent approaches but both methods showed that anaerobic Gram-negative bacilli and Gram-positive cocci were the most commonly identified in DFI. Anaerobes were more present in deeper lesions, and their detection was associated with fever, malodorous lesions, and ulcer depth and duration. More specifically, initial abundance of Peptoniphilus spp. was associated with ulcer-impaired healing, Fusobacterium spp. detection was significantly correlated with the duration of DFI, and the presence of Bacteroides spp. was significantly associated with amputation. Antimicrobial resistance of anaerobes in DFI remains slightly studied and warrants more consideration in the context of increasing resistance of the most frequently identified anaerobes in DFI. The high rate of patients with DFI-involving anaerobes, the increased knowledge on the species identified, their virulence factors, and their potential role in wound evolution support recommendations combining debridement and antibiotic therapy effective on anaerobes in moderate and severe DFI.